文献速递产科妇科

采用包含M6模型的两步方案对未知位置妊娠女性进行分诊:临床实施研究

Triaging women with pregnancy of unknown location using two-step protocol including M6 model: clinical implementation study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

本研究为前瞻性多中心干预研究,纳入2015年1月至2017年1月英国四所地区综合医院和四所大学教学医院的3272例未知位置妊娠(PUL)女性,验证以孕酮≤2 nmol/L为第一步、M6模型为第二步的两步方案分诊性能。最终分析2625例,55.0%被归为低风险,其中1.0%最终诊断为异位妊娠(EP),无破裂或严重临床伤害;62例发生不良事件,无严重不良事件。

要点

  • 两步方案将55.0%(1445/2625)的PUL归为低风险,其中仅1.0%为EP。
  • 高风险组901例中30.5%为EP,275/320(85.9%)的EP被正确归为高风险。
  • 62例发生不良事件,无英国GCP定义的严重不良事件。

核心结论

  • 包含M6模型的两步方案有效将多数PUL女性归为EP低风险,仅需两次就诊即可完成随访。
  • 误分类的EP很少,且无一例导致显著临床伤害或严重不良临床事件。
  • 该两步方案是合理化PUL女性管理的有效且临床安全的方式。

研究设计与样本

  • 前瞻性多中心干预研究,2015年1月至2017年1月在英国四所地区综合医院和四所大学教学医院开展。
  • 共纳入3272例PUL女性,最终分析2625例;317例符合排除标准或失访,330例因使用孕酮≤10 nmol/L切值而单独分析。
  • 所有患者就诊时检测血清孕酮和hCG;孕酮≤2 nmol/L者出院并于2周后复查尿妊娠试验,孕酮>2 nmol/L或未检测者48小时复查hCG并输入M6模型。

主要发现

  • 第一步中407例(15.5%)孕酮≤2 nmol/L归为低风险,其中7例(1.7%)最终诊断为EP。
  • 剩余2218例中279例因方案偏离或第二次hCG前已明确结局未应用M6模型,其中30例诊断为EP。
  • 第二步中1038例归为低风险,其中8例(0.8%)最终为EP;901例归为高风险,其中275例(30.5%)为EP。
  • 275/320(85.9%)的EP被正确归为高风险;总体1445/2625(55.0%)归为低风险,其中15例(1.0%)为EP,无一例发生破裂EP或显著临床伤害。
  • 62例参与研究的女性发生不良事件,但无英国GCP指南定义的严重不良事件。

关键数值与推荐

  • 第一步以初始孕酮≤2 nmol/L识别可能失败妊娠。
  • 第二步将hCG结果输入M6模型,高风险定义为EP风险≥5%,高风险者在48小时内临床复评。
  • 低风险可能失败PUL建议2周后尿妊娠试验,低风险可能宫内妊娠建议1周后超声检查。

临床怎么用

  • 本方案按预测结局管理患者:低风险可能失败PUL建议2周后尿妊娠试验,低风险可能宫内妊娠建议1周后超声,高风险者在48小时内临床复评。
  • 一个中心使用孕酮≤10 nmol/L切值,其数据单独分析。
  • 未遵循推荐管理方案时记录为方案偏离,分为临床原因非计划就诊、患者原因非计划就诊或血检/超声时间不正确。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The M6 risk-prediction model was published as part of a two-step protocol using an initial progesterone level of ≤ 2 nmol/L to identify probable failing pregnancies (Step 1) followed by the M6 model (Step 2). The M6 model has been shown to have good triage performance for stratifying women with a pregnancy of unknown location (PUL) as being at low or high risk of harboring an ectopic pregnancy (EP). This study validated the triage performance of the two-step protocol in clinical practice by evaluating the number of protocol-related adverse events and how effectively patients were triaged. METHODS: This was a prospective multicenter interventional study of 3272 women with a PUL, carried out between January 2015 and January 2017 in four district general hospitals and four university teaching hospitals in the UK. The final pregnancy outcome was defined as: a failed PUL (FPUL), an intrauterine pregnancy (IUP) or an EP (including persistent PUL (PPUL)). FPUL and IUP were grouped as low-risk and EP/PPUL as high-risk PUL. Serum progesterone and human chorionic gonadotropin (hCG) levels were measured at presentation in all patients. If the initial progesterone level was ≤ 2 nmol/L, patients were discharged and were asked to have a follow-up urine pregnancy test in 2 weeks to confirm a negative result. If the progesterone level was > 2 nmol/L or a measurement had not been taken, hCG level was measured again at 48 h and results were entered into the M6 model. Patients were managed according to the outcome predicted by the protocol. Those classified as 'low risk, probable FPUL' were advised to perform a urine pregnancy test in 2 weeks and those classified as 'low risk, probable IUP' were invited for a scan a week later. When a woman with a PUL was classified as high risk (i.e. risk of EP ≥ 5%) she was reviewed clinically within 48 h. One center used a progesterone cut-off of ≤ 10 nmol/L and its data were analyzed separately. If the recommended management protocol was not adhered to, this was recorded as a protocol deviation and classified as: unscheduled visit for clinician reason, unscheduled visit for patient reason or incorrect timing of blood test or ultrasound scan. The classifications outlined in the UK Good Clinical Practice (GCP) guidelines were used to evaluate the incidence of adverse events. Data were analyzed using descriptive statistics. RESULTS: Of the 3272 women with a PUL, 2625 were included in the final analysis (317 met the exclusion criteria or were lost to follow-up, while 330 were evaluated using a progesterone cut-off of ≤ 10 nmol/L). Initial progesterone results were available for 2392 (91.1%) patients. In Step 1, 407 (15.5%) patients were classified as low risk (progesterone ≤ 2 nmol/L), of whom seven (1.7%) were ultimately diagnosed with an EP. In 279 of the remaining 2218 women with a PUL, the M6 model was not applied owing to protocol deviation or because the outcome was already known (usually on the basis of an ultrasound scan) before a second hCG reading was taken; of these patients, 30 were diagnosed with an EP. In Step 2, 1038 women with a PUL were classified as low risk, of whom eight (0.8%) had a final outcome of EP. Of 901 women classified as high risk at Step 2, 275 (30.5%) had an EP. Therefore, 275/320 (85.9%) EPs were correctly classified as high risk. Overall, 1445/2625 PUL (55.0%) were classified as low risk, of which 15 (1.0%) were EP. None of these cases resulted in a ruptured EP or significant clinical harm. Sixty-two women participating in the study had an adverse event, but no woman had a serious adverse event as defined in the UK GCP guidelines. CONCLUSIONS: This study has shown that the two-step protocol incorporating the M6 model effectively triaged the majority of women with a PUL as being at low risk of an EP, minimizing the follow-up required for these patients after just two visits. There were few misclassified EPs and none of these women came to significant clinical harm or suffered a serious adverse clinical event. The two-step protocol incorporating the M6 model is an effective and clinically safe way of rationalizing the management of women with a PUL. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bobdiwala S, Christodoulou E, Farren J, et al. Triaging women with pregnancy of unknown location using two-step protocol including M6 model: clinical implementation study. Ultrasound Obstet Gynecol. 2020. PMID: 31385381. doi:10.1002/uog.20420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。